异维 A 酸联合他克莫司软膏治疗脂溢性皮炎的有效性及安全性探讨
实用外科创新(Applied Surgical Innovations) · 2026
DOI: 10.66106/swcabp.20260308 ↗Kurz gefasst
Fachartikel in der Zeitschrift 实用外科创新(Applied Surgical Innovations), 2026. Verfasst von 王凤娟 Fengjuan Wang. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Abstract:Objective:To evaluate the efficacy,safety,treatment satisfaction and short-term recurrence rate of oral isotretinoin combined with topical tacrolimus ointment in the treatment of seborrheic dermatitis(SD). Methods:A total of 120 patients with SD diagnosed at the dermatology outpatient clinic of our hospital from January to December 2025 were enrolled and randomly divided into combination group(n=60)and control group(n=60). The combination group received oral isotretinoin(0.3 mg/(kg·d))plus topical 0.1% tacrolimus ointment,while the control group received 0.1% tacrolimus ointment alone;the treatment duration was 8 weeks for both groups. Clinical efficacy,adverse events,treatment satisfaction and recurrence rate within 4 weeks after treatment were compared between the two groups. Results:The total effective rate of the combination group was 100.0%(60/60),higher than 91.7%(55/60)of the control group(P
Zitieren
APA
Wang, 王. F. (2026). 异维 A 酸联合他克莫司软膏治疗脂溢性皮炎的有效性及安全性探讨. 实用外科创新(Applied Surgical Innovations). https://doi.org/10.66106/swcabp.20260308
Vancouver
Wang 王F. 异维 A 酸联合他克莫司软膏治疗脂溢性皮炎的有效性及安全性探讨. 实用外科创新(Applied Surgical Innovations). 2026. doi:10.66106/swcabp.20260308
BibTeX
@article{Wang2026,
author = {Wang, 王凤娟 Fengjuan},
title = {异维 A 酸联合他克莫司软膏治疗脂溢性皮炎的有效性及安全性探讨},
journal = {实用外科创新(Applied Surgical Innovations)},
year = {2026},
doi = {10.66106/swcabp.20260308}
}
EUVIMED